ZA957949B - Methods of inhibiting endometrial mitroses - Google Patents

Methods of inhibiting endometrial mitroses

Info

Publication number
ZA957949B
ZA957949B ZA957949A ZA957949A ZA957949B ZA 957949 B ZA957949 B ZA 957949B ZA 957949 A ZA957949 A ZA 957949A ZA 957949 A ZA957949 A ZA 957949A ZA 957949 B ZA957949 B ZA 957949B
Authority
ZA
South Africa
Prior art keywords
mitroses
methods
inhibiting endometrial
endometrial
inhibiting
Prior art date
Application number
ZA957949A
Other languages
English (en)
Inventor
Susan Margaret Boss
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA957949B publication Critical patent/ZA957949B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
ZA957949A 1994-09-22 1995-09-20 Methods of inhibiting endometrial mitroses ZA957949B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/310,292 US5843964A (en) 1994-09-22 1994-09-22 Methods of inhibiting endometrial mitoses

Publications (1)

Publication Number Publication Date
ZA957949B true ZA957949B (en) 1997-03-20

Family

ID=23201835

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957949A ZA957949B (en) 1994-09-22 1995-09-20 Methods of inhibiting endometrial mitroses

Country Status (16)

Country Link
US (1) US5843964A (no)
EP (1) EP0782446A4 (no)
JP (1) JPH10506108A (no)
KR (1) KR970706000A (no)
CN (1) CN1158086A (no)
AU (1) AU692309B2 (no)
CA (1) CA2200451A1 (no)
CZ (1) CZ83997A3 (no)
FI (1) FI971197A (no)
HU (1) HUT76828A (no)
IL (1) IL115383A0 (no)
MX (1) MX9702148A (no)
NO (1) NO971029L (no)
NZ (1) NZ294123A (no)
WO (1) WO1996009050A1 (no)
ZA (1) ZA957949B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115022A (en) * 1994-08-22 2000-07-31 Lilly Co Eli Pharmaceutical compositions for inhibiting endometrial cancer
AU777770C (en) 1999-05-04 2005-11-10 Strakan International Limited Androgen glycosides and androgenic activity thereof
US8955556B2 (en) 2011-06-30 2015-02-17 Hellermanntyton Corporation Cable tie tensioning and cut-off tool
USD692738S1 (en) 2011-06-30 2013-11-05 Hellermanntyton Corporation Cable tie tensioning and cut-off tool
WO2016094855A1 (en) 2014-12-12 2016-06-16 Hellermanntyton Corporation Compound tension and calibration mechanism for cable tie tensioning and cut-off tool

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
WO1996005832A1 (en) * 1994-08-22 1996-02-29 Eli Lilly And Company Methods of inhibiting primary endometrial hyperplasia

Also Published As

Publication number Publication date
US5843964A (en) 1998-12-01
FI971197A0 (fi) 1997-03-21
JPH10506108A (ja) 1998-06-16
CN1158086A (zh) 1997-08-27
FI971197A (fi) 1997-03-21
EP0782446A4 (en) 1999-01-07
CA2200451A1 (en) 1996-03-28
AU692309B2 (en) 1998-06-04
WO1996009050A1 (en) 1996-03-28
NZ294123A (en) 1999-09-29
AU3678895A (en) 1996-04-09
KR970706000A (ko) 1997-11-03
NO971029D0 (no) 1997-03-06
IL115383A0 (en) 1995-12-31
CZ83997A3 (en) 1997-07-16
MX9702148A (es) 1997-06-28
EP0782446A1 (en) 1997-07-09
HUT76828A (en) 1997-11-28
NO971029L (no) 1997-03-06

Similar Documents

Publication Publication Date Title
PL327569A1 (en) Promedications of thrombosin inhibitors
PL311736A1 (en) Derivatives of 1h-imidazoles
PL329875A1 (en) Derivatives of carbolin
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL319163A1 (en) Inhibitors of 5 alpha-reductase
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
GB9400538D0 (en) Hydrate inhibition
HU9700071D0 (en) Use of muramilpeptides
HU9503783D0 (en) Squvalen syntetase inhibitors
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
ZA957949B (en) Methods of inhibiting endometrial mitroses
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
IL115022A0 (en) Methods of inhibiting endometrial cancer
DE69523450D1 (en) Inhibitor
IL108595A0 (en) Novel derivatives of tetramethylcyclopropane
SG49610A1 (en) Novel inhibitor
GB9400692D0 (en) Methods of assay
ZA946331B (en) Pyran-4-ylmethyl-substituted arylalkylaryl- arylalkenylylaryl- and arylalkynylarylurea inhibitors of 5-lipoxygenase